Equstech

At Equstech, we are revolutionizing equine health through cutting-edge, non-invasive technology that enhances healing, improves performance, and extends the longevity of equine athletes. Our flagship innovation, the K2 device, represents a groundbreaking advancement in veterinary technology, utilizing bioelectric stimulation to optimize the body's natural healing processes. Why Equstech? Equine athletes endure intense physical demands, leading to injuries, inflammation, and prolonged recovery times that hinder performance. Traditional treatments often rely on invasive procedures, pharmaceuticals, or lengthy rehabilitation periods. At Equstech, we believe in a smarter, science-driven approach—one that accelerates recovery without compromising the horse's well-being. The K2 Advantage The K2 device harnesses the power of Directed Cellular Mobility Current (EDCMC) technology, leveraging controlled electrical fields to stimulate tissue repair, reduce inflammation, and alleviate pain. This state-of-the-art therapy guides cellular migration to injury sites, significantly shortening recovery times while improving the quality and durability of healing. 🔹 Faster Recovery – Reduces downtime and gets horses back to peak performance sooner. 🔹 Non-Invasive Treatment – Avoids surgery and pharmaceuticals, prioritizing equine safety. 🔹 Optimized Performance – Maintains strength, flexibility, and overall well-being. Shaping the Future of Equine Care Equstech is setting a new standard in equine rehabilitation and performance optimization. Our mission is to empower veterinarians, trainers, and horse owners with advanced tools that ensure horses recover stronger, faster, and safer than ever before. 🔬 Science-Driven. Performance-Focused. Compassion-Led. 🌍 Join us in redefining equine healthcare. Learn more at www.equstech.com

• Employees 1
• Founded 2017